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The ability to form carbon-carbon bonds, arguably the most important 
transformation in synthetic chemistry, has been critically facilitated via the 
implementation of transition metal catalysts with main group element-associated 
carbon moieties. Specifically, organosilane coupling technology previously reported 
in the DeShong group provides ease of access to a wide variety of structurally 
important carbon-carbon bond motifs. The stability, tolerance of numerous implicit 
functional groups, simplicity of use, and ease of synthetic access to a multitude of 
organosilane coupling partners, makes the coupling technology developed in the 
DeShong lab markedly attractive for implementation in syntheses of complex natural 
product targets. Two targets of specific interest are pancratistatin and streptonigrin. 
Synthetic approaches toward pancratistatin via complex organosilane coupling 
precursors proved promising, however mechanistic studies performed in the DeShong 
  
group determined that standard 18-electron palladium(0) catalysts fail in 
transmetallation. Therefore, a new class of 16-electron Pd(0) catalysts have been 
developed and surveyed for applications in siloxane based allyl-aryl coupling 
protocols. The ability to "tune" these catalysts' activity by varying either the cone 
angle or the electronic characteristics of the alkene ligands attached to palladium has 
also been demonstrated. Unfortunately, attempts to prepare chiral adducts in the 
coupling reaction utilizing chiral bicyclooctadiene derivatives as a ligand for 
palladium provided no significant enantioenrichment in the coupled product. 
Similarly, previous work in the DeShong lab toward the synthesis of 
streptonigrin has been reported. Particularly, the synthesis of the structurally 
congested pyridyl C-ring proved difficult, requiring numerous steps at low yields. 
Development of new synthetic pathways toward the pyridyl C-ring was undertaken, 
exploiting the electronically withdrawn nature of the pyridone intermediate in order 
to brominate and alcohol, as well as change a methyl group to an aldehyde, via an 
enamine intermediate. 
The specific goals of this work were (1) to investigate new palladium(0) 
catalysts for the coupling of analogues of pancratistatin precursors, and (2) to 
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 Transition-metal complexes have found a wide variety of uses in organic 
synthesis, due in part to their versatility and ease of access to transformations that 
would otherwise prove difficult or inaccessible. The ability to form carbon-carbon 
bonds, arguably the most important transformation in synthetic chemistry, has been 
critically facilitated via the implementation of transition metal catalysts with main 
group element-associated carbon moieties.1-3 The difficulty in carbon-carbon bond 
formation arises from the fact that, in most cases, the targeted coupling carbon centers 
possess identical electronegativities, and thus no affinity for binding. Through 
covalent association with any number of varying main group metals, the relative 
nucleophilicity of the metal-bound carbon atom can be modified, thus increasing its 
reactivity toward an electrophilic species.  
The most widely used transition metal for the electrophilic activation of 




organometallic electrophilic species have been developed, each with their own 
















The most commonly used organometallic reagents for cross-coupling include 
organostannanes (Stille coupling),4 organoboron compounds (Suzuki coupling),5 and 
organosilanes (Hiyama coupling).6  
While Stille couplings generally provide good-to-excellent yields of the 
desired coupled product, while simultaneously tolerating a wide array of functional 
groups present in the coupling partners, issues arise in the difficulty of removal of the 
tin reagents from the reaction products. Given the toxicity of the organostannane 
byproducts remaining in the final product, Stille coupling is not suitable in the 
synthesis of compounds that may be used in vivo, thus limiting its scope. 
Suzuki coupling technology improved upon several of the shortcomings of 
Stille coupling chemistry. While still high yielding in coupled product and tolerant of 
numerous functional groups, Suzuki coupling employs organoboron compounds 
(boronic acids and esters), which are both less toxic and easier to remove from the 
reaction products than its Stille coupling, organostannane counterpart. These 




biologically active target molecules, thus leading Suzuki coupling to be embraced and 
widely implemented by the pharmaceutical industry. However, Suzuki coupling has 
its limitations, namely the synthesis, purification, and instability of boronic acids, 
which are more reactive toward coupling than their boronic ester counterparts. Also, 
organoboron compounds will not tolerate Lewis basic functionalities. 
Provided these successes and shortcomings, further advancement in main 
group element-bound nucleophiles came with the development of Hiyama’s 
organosilane technology. These silicon-coupling precursors are tolerant of various 
functional groups, less toxic than organostannanes, inexpensive and easily accessible, 
able to be chromatographically purified, and are tremendously robust until activated.7 
The scope, mechanistics, and applicability of palladium-catalyzed organosilane cross-
couplings has been thoroughly investigated in the DeShong group, as well in the 
Denmark group and others.8-14 
 
Amaryllidaceae Natural Products 
 The Amaryllidaceae family of plants is home to several subfamilies of 
alkaloid producing organisms, including Agapanthoideae (lily of the Nile), Allioideae 
(onion, garlic, leek), and Amaryllidoideae (Amaryllis). It was determined by the 
National Cancer Institute that some species of the Amaryllidaceae family contain 
alkaloids that had varying degrees of anticancer character. The large number of 
biologically relevant natural products isolated from this family of plants led Pettit and 
coworkers to investigate Pancratium littorale (Hawaiian daffodil), ultimately leading 













1, (+)-pancratistatin, R = OH
2, (+)-7-deoxypancratistatin, R = H
7
 
Figure 1. Structure of Amaryllidaceae alkaloids 
 
Studies conducted in the late 1980s - early 1990s by the National Cancer Institute 
provided a greater insight into the scope of action of (+)-pancratistatin (1) toward 
various cancer cell lines, including notable inhibition of growth in ovarian 
sarcoma.16,17 Similar studies have gone on to show that (+)-pancratistatin (1) is 
selectively apoptotic toward colon,18 prostate,19 leukemia,20 lymphoma,21 
neuroblastoma,22 and melanoma23 cancer cell lines in micromolar dosages. The 
structurally similar, though significantly less biologically active,24,25 (+)-7-
deoxypancratistatin (2) was isolated from Scadoxus multiflorus (blood lily, formerly 
Haemanthus kalbreyeri) by Ghosal and coworkers in 1989.26 
Beyond marked anticancer capabilities, both (+)-pancratistatin (1) and (+)-7-
deoxypancratistatin (2) have been shown to have significant antiviral activity against 
certain RNA flaviviruses (Japanese encephalitis, yellow fever, and dengue fever) and 
bunyaviruses (Punta Toro and Rift Valley fever).24 Attempts at intensifying the 
biological activity through synthetic derivation of key structural and functional 




vain; both natural products displayed higher bioactivity than any unnatural 
analogues.27-30 
The promising biological activity of (+)-pancratistatin (1) was tempered, 
however, by the low natural abundance of the compound in the dry plant bulb 
biomass (45 kg of bulb sections provided just 6.5 g of racemic pancratistatin, 
0.028%).15 Without a consistent natural supply available, the future of clinical studies 
and potential implementation as a therapy would rely upon the discovery of a 
practical synthetic means of access.  
 
Synthetic Approaches Toward Pancratistatin and Analogues 
 The synthetic community has shown great interest in (+)-pancratistatin (1) and 
its analogues, not only for their potential as desirable therapies for various diseases, 
but also for their synthetic complexity. The structures of (+)-pancratistatin (1) and 
(+)-7-deoxypancratistatin (2) are stereochemically complex, with the cyclohexyl C-
ring containing six contiguous stereocenters, one of which is the attachment point to 
the aryl A-ring. The A- and C-rings are fused futher via a trans lactam B-ring (Figure 
1). 
The majority of syntheses of pancratistatin and its analogues rely 
predominantly on the enantioselective formation of the bond between the aryl A-ring 
and the cyclohexyl C-ring, though approaches toward forming this connection span a 



















































































1, (+)-pancratistatin, R = OH
 
Figure 2. Survey of synthetic strategies for (+)-pancratistatin and analogues. 
Modified from reference 55 
 
One of the earliest total syntheses of (+)-7-deoxypancratistatin (2), focusing 
on the formation of the A-C ring bond, was reported by Hudlicky in 1995.31,32 By 
employing an aryl cuprate precursor of the A-ring as the nucleophile in the SN2 ring 
opening of an aziridine appended to a C-ring precursor, the trans stereochemistry of 
the A-C ring bond and the B-ring lactam fusion site were established in a single step 






























The steric bulk of the acetonide-protected diol present in the C-ring precursor also 
imparted regioselectivity upon the nucleophilic addition of the aryl substrate, 
providing the desired ring-attachment position. While elegant and concise in its 
approach to establishing both the regio- and stereochemical aspects of the ring fusion 
points in the natural product, Hudlicky’s synthesis of (+)-7-deoxypancratistatin (2) 
was hindered by the relatively low yields reported in these steps, as displayed in 
Scheme 2, as well as the difficulty in preparation and instability of the A- and C-ring 
precursors. That being said, Hudlicky’s synthetic intermediate proved an attractive 
target for our formal total synthesis, due to advancements in access to analogues of 
his C-ring precursor, and their tolerance toward our developed coupling methodology 
(vide infra). 
 Also published in 1995, the next notable synthesis of (+)-pancratistatin (1) 
was completed by Trost.33 The formation of the A-C ring system was approached via 
the nucleophilic SN2’ addition of an aryl Grignard A-ring precursor to an allyl 























(19 total steps, 8% yield)
 
 
The reported instability of Trost’s azido A-C ring intermediate precluded isolation 
and characterization, requiring immediate cis-dihydroxylation of the C-ring olefin in 
order to properly distinguish the regio- and stereochemical outcome the SN2’ reaction. 
Length ultimately encumbered Trost’s synthesis, as well as observed instability in the 
prepared precursors. Also, several important procedures from this synthesis have 
gone unreported. 
 Magnus next completed a total synthesis of (+)-pancratistatin (1) in 1998.34,35 
Treating an aryl bromide A-ring precursor with n-butyl lithium provided an aryl 
anion, which was subsequently introduced to a protected cyclohexanone C-ring 

























While Magnus’s nucleophilic acyl addition provided an A-C ring intermediate in high 
yield, it lacked stereocontrol, thus providing racemic product. In order to attain the 
targeted product stereochemistry, dehydration, hydrogenation, deprotection, and 
subsequent treatment with a chiral amide base were required, all adding to the length 
and low overall yield of this synthetic approach. 
 In 2000, Rigby and coworkers proposed a photocyclic means of approach to 
(+)-pancratistatin.36 By exploiting the hydrogen-bonding interaction present between 
the phenolic hydrogen and the aryl enamide carbonyl oxygen, Rigby set the 
conformation of the starting material such that in would readily undergo 
photocyclization to provide the desired ring-fusion product in the proper 

















(23 total steps, 0.35% yield)
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While cleverly planned, the low overall yield and significant number of steps required 
make this synthesis unattractive in practice. 
 Also in 2000, Plumet approached the synthesis of (+)-7-deoxypancratistatin 
(2) by way of ring opening a bicyclic ether bridge.37 Through the treatment of a 




addition to the bicyclic C-ring precursor, which then proceeded through and allylic 




















(21 total steps, 3% yield)
 
 
While the conformation of the bicyclic system directed the stereoselectivity of A-ring 
addition, providing the desired A-C ring fusion stereochemistry in excellent yield, 
synthetically rigorous starting materials, overall length, and low total yield hurt 
Plumet’s synthesis. 
 Hudlicky continued work on this topic, publishing a seminal article in 2002 
describing various syntheses of pancratistatin and its analogues, including one of the 
first reported uses of palladium-catalyzed Suzuki cross-coupling in the synthesis of 
the analogue narciclasine.38 Coupling of an aryl boronic acid A-ring with a dibromo 
oxazine tricycle using a catalytic amount of Pd(PPh3)4 proceeded in good yield, 























































Ring opening of the oxazine tricycle was noteworthy, in that it provided easy access 
to the desired stereochemistry in the subsequent carbamate, which was then used for 
the formation of the B-ring lactam. Both the implementation of palladium coupling 
technology, and the usage of stereochemically-dense tricycles would prove useful in 
future synthetic pathways developed in the DeShong group (vide infra).   
 In 2006, Li reported one of the highest yielding and shortest routes toward the 
synthesis of (+)-pancratistatin to date.39 By employing pinitol as a starting material, a 
near stereochemical duplicate of pancratistatin’s C-ring, much of the length reported 
in previous syntheses could be avoided. Through the creation of an aryl cerium 
nucleophile, Li was able to affect an intramolecular ring closure through the opening 
of a cyclic sulfate, affording the complete skeleton of the natural product with desired 




























(13 total steps, 9% yield)
t-BuLi, CeCl3
ultrasound, THF




While high yielding and expedient, the prohibitive cost of pinitol dramatically effects 
the viability Li’s synthesis. 
 More recently, Cho has described the synthesis of racemic pancratistatin by 
way of an inverse electron-demand Diels-Alder cycloaddition between a borylstyrene 
A-ring analogue and dibromo pyrone.40,41 The endo selectivity exhibited in the Diels-
Alder cycloaddition reaction provided the desired stereochemistry at the A-C ring 
junction. Upon formation of the cycloaddition adduct, subsequent boronate cleavage, 
debromination, and methanolysis of the bicycle produced the distinguishable A-C 









































While seemingly innocuous, the formation of the dibromo pyrone starting material 
proved synthetically challenging, and the resulting C-ring substituent stereochemistry 
in Cho’s A-C intermediate required an inversion at the highlighted position, adding to 
the overall synthetic length. 
 The most recent synthesis of (+)-pancratistatin was reported by Alonso in 
2012.42 By treating dioxanone with a chiral pyrrolidine, a chiral enamine intermediate 
was generated, which upon introduction to an A-ring precursor aryl nitro enal, 























rt 38%, 75% ee
1
(15 total steps, 1.6% yield)  
 
While an interesting application of a chiral pyrrolidine auxiliary, the subsequent 
annulation was low yielding, while providing only good enantioenrichment. Required 
recrystallizations to provide enantiopure products throughout Alonso’s synthesis 





Synthetic Approaches Toward 7-Deoxypancratistatin in the DeShong Group 
Advances in palladium-catalyzed organosilane allyl-aryl cross-coupling 
methodologies have been made in the DeShong group, with the goal of being able to 
achieve a coupled, late-stage intermediate of the 7-deoxypancratistatin A-C ring 


























Figure 3. Proposed retrosynthesis of 7-deoxypancratistatin 
 
Through the use of previously installed stereocenters in the readily accessible starting 
materials, the direction of the regio- and stereochemical outcomes of the palladium-
catalyzed coupling to create the desired late-stage A-C ring intermediate should be 
attainable. For the reasons mentioned previously, we determined the use of our 
organosilane coupling technology is advantageous to the formation of this complex 
coupled product. 
Initially, proof-of-concept studies into the regioselectivity of organosilane 
palladium-catalyzed allyl-aryl coupling of simplified analogues were undertaken. 
Investigation into the palladium-catalyzed coupling of trans-4-methylcyclohex-2-en-




silicate-based phenyl source that has been extensively studied in the DeShong 
























After associating with the π-system, the palladium complex can displace the benzyl-
protected alcohol from the anti- face in an SN2 fashion with inversion of 
configuration, providing the π-allyl intermediate shown. Upon transmetallation of the 
phenyl group from the activated TBAT silicate, there remains a regiochemical 
question for the subsequent reductive elimination. The strength of the phenyl 
nucleophile predicates its addition to the palladium center in the π-allyl intermediate, 
providing the relative stereochemistry of the nucleophilic addition. Reductive 
elimination would be predicted to provide a cis coupled product, an overall inversion 












Figure 4. Unsymmetrical transmetallated π-allyl palladium intermediate 
 
Ultimately, support for the regiochemical outcome can be gathered by observing the 
asymmetry in the π-allyl intermediate (Figure 4). The steric bulk of the methyl group 
at the 4-position would encumber the palladium species from residing predominantly 
over the 3-position as a π-allyl, or similarly as a σ-complex bound at the 3-position. 
Upon reductive elimination, one would expect notable product to derive from the 
more stable intermediate geometry of a σ-complex bound at the 1-position, which 
was experimentally observed in the regioisomeric product ratios. 
  With the result of this investigation being in agreement with the accepted 
mechanistic model, further extrapolation in complexity with regard to the coupling 
partners employed was studied. By installing a carbamate functionality into the π-
allyl precursor moiety, cis-4-ethyl carbamate cyclohex-2-en-1-yl ethyl carbonate (4), 
the opportunity for the formation of the B-ring lactam which would complete the 
carbon skeleton of the target molecule with proper stereochemistry (5) via a Bischler-
Napieralski cyclization would be available, provided the coupling reaction gave the 






































Similarly to the initial proof-of-concept studies, displacement by the palladium 
complex of the carbonate leaving group occurs from the face anti to the leaving 
group, providing the intermediate show above. Once again, given the highly 
nucleophilic nature of the activated fluorosilicate intermediate of the aryl 
alkoxysilane transfer reagent used, the relative stereochemistry observed at the 
position of coupling can be reasoned to arise via transmetallation with the π-allyl 













In this instance, however, the regioselectivity displayed in the coupling reaction was 
low, due to the lack of a sterically directing group occupying a position on the same 
face as the palladium complex. By this absence of a capable steric occupant in the π-
allyl intermediate, residence of the transmetallated palladium complex in any of the 
σ1-π-σ3 isomers should be statistically equivalent, therefore providing only modest 
















Figure 6. σ1-π-σ3 isomerization in the symmetrical transmetallated π-allyl palladium 
intermediate 
 
Work by Szabó and coworkers further elucidates a conformational bias experienced 
in the trans π-allyl palladium intermediates derived from 1,4 disubstituted 
cyclohexenes of this type, leading to favorable reductive elimination from the 1-
position, thereby explaining the slight variance from statistical distribution in 
regioisomeric coupled product ratio observed.47 
 By further derivatization of the coupling precursor to include an acetonide-
protected diol (6), it was envisioned that a steric bias could be imparted on the π-allyl 




desired C-3 position of the π-allyl system in the subsequent reductive elimination to 














Figure 7. Complex asymmetric π-allyl palladium intermediate 
 
While allowing for the previously absent coupling-site direction, the inclusion of the 
bulky protected diol would also set two stereocenters that are present in the natural 













































Unfortunately, the coupling reaction did not proceed as expected, failing to provide 
the desired coupled product.48 It was initially reasoned that the steric bulk of the 
acetonide protecting group was too substantial for the palladium(0) substrate to either 
complex with the π-system then displace the leaving group in the coupling precursor, 
or, if that were successful, to allow the activated aryl fluorosilicate nucleophile 
subsequent access to the π-allyl palladium intermediate to undergo transmetallation. 
In order to better identify the cause of our coupling process shortcomings, it was 
determined that the Tsuji-Trost coupling methodology would provide valuable insight 
into where in the coupling cycle the reaction failed. 
 It was envisioned that, by implementing Tsuji-Trost technology, it could be 
determined if the steric bulk from the acetonide protection of the diol was too great 
for the initial palladium(0) complexation or leaving group displacement to occur. In 
Tsuji-Trost coupling, oxidatively-inserted palladium(II) species are displaced by the 
addition of weak nucleophiles, via an anti- addition to the allyl moiety with respect to 
the palladium center.49 Provided the anti- face of approach for the nucleophile is 
much less sterically congested, the outcome of the Tsuji-Trost coupling will be solely 











EtOOC COOEt  
Figure 8. Proposed Tsuji-Trost coupling intermediate  
 
If Tsuji-Trost coupling product were to be observed, it would follow that the 
palladium π-allyl intermediate shown in Scheme 13 and Figure 8 was indeed being 
formed, despite the steric encumbrance presented by the acetonide group, and that our 
previously attempted coupling to form the late-stage natural product intermediate 
(Scheme 13) was impeded at the transmetallation stage of the coupling cycle. 
 With this in mind, a proof-of-concept investigation with basic coupling 
partners, analogous to our desired complex systems, was undertaken in order to 
examine the general efficacy of the Tsuji-Trost coupling technology with our model 

























EtOOC COOEt  
 
The stereoselectivity of this basic Tsuji-Trost coupling follows the expected approach 
of the nucleophile from the anti- face in relation to the π-allyl palladium intermediate, 
providing an overall retention of stereochemistry from the starting material (arising 
from an inversion-inversion). Similarly, the regiospecificity displayed in the coupled 
product arises from a favorable nucleophilic attack at the less hindered 1-position, 
compared to a 3-position approach which is effectively blocked by the 4-position 
carbamate residing on the face of addition. 
 With the Tsuji-Trost technology proving efficacious with our basic coupling 
system analogue, extrapolation to our desired coupling precursor (6), to test if the 
palladium(0) complex was capable of achieving leaving group displacement, could 




































Interestingly, and to the benefit of our projected couplings for the formation of the 
carbon skeleton of Amaryllidaceae natural product targets, the observed 
regioselectivity of addition of the malonate nucleophile goes against the predicted 
steric effects in the proof-of-concept studies (Scheme 14). From said studies, product 
arising from malonate addition at the 1- position (B) was expected to predominate, 
provided the steric encumbrance that was projected to occur during a 3- position 
addition (A) due to the bulk of the carbamate in the 4- position residing on the same 
face of addition. It was rationalized that the regioselectivity of addition was 
predicated upon the relative overall balance between the steric interaction of the 
palladium(II) complex with the acetonide protected diol, forcing the complex to 
reside more toward the 3- position and thus yielding product A, versus the 
electrostatic interaction of the positively-charged palladium(II) complex and the lone 
pairs of oxygen in the acetonide protected diol, pulling the complex toward the 1- 
position and providing product B upon nucleophilic addition (Scheme 16).50 
 
































With the observation of Tsuji-Trost coupled products arising from our 
complex coupling intermediate, it can be established that the π-allyl palladium 
intermediate must be forming despite the congested sterics. This also suggests that the 
underlying issue with our original complex allyl-aryl coupling process must be the 
inability of the π-allyl palladium complex to undergo transmetallation. In order to 
better understand the mechanistic aspects of our allyl-aryl coupling, with a specific 
focus on the transfer of the aryl group during transmetallation, a Hammett Analysis of 
the coupling of various aryl silicate derivatives with a standard allyl carbonate was 
undertaken.51 
The proposed mechanism for our allyl-aryl coupling follows the expected 
route: rapid activation of aryl siloxane 7 with the TBAF fluoride source to produce a 
pentacoordinate silicate (8), while palladium(0) catalyst displaces the carbonate 
leaving group in the allyl carbonate moiety of 9. Transmetallation of the activated 
silicate with the π-allyl palladium complex provides intermediate 10, which, upon 
reductive elimination, yields our desired allyl-aryl coupled product 11 (Scheme 17, 



































By examining the effects incorporating a variety of electron-donating and electron-
withdrawing substituents into the aryl silicate moiety had on the relative rates of 
coupling compared to an unsubstituted aryl silicate, information was gathered 
regarding the electronic character of the predicted transition state (Scheme 18, 























Si(OEt)3 Si(OEt)3 Si(OEt)3 Si(OEt)3 Si(OEt)3
CO2EtClHMeOMe
0.42 0.72 1.0 3.4 4.2
Relative rate of coupling reactions  
 
The information provided by the Hammett correlation was twofold: (1) the relative 
rates for the coupling reactions were enhanced through the presence of an electron-
withdrawing group, leading to the belief that our proposed coupling mechanism and 
transition state were accurate, as the development of negative charge on the aryl ring 
during the transition state would be better stabilized by the presence of an EWG via 
inductive effects, and (2) the observation in correlation between aryl silicate 
modification and the relative rate of the coupling reaction corroborates that 
transmetallation is the rate-determining step in our mechanism.51 
 To this point, the 18-electron Pd(dba)2 catalyst had been our chosen source of 
Pd(0), given its relative stability, ease of use, and ubiquity of employment throughout 
the literature.52-54 Provided the success of the Hammett analysis on our allyl-aryl 




catalyst parameters on transmetallation was begun.51 Without a more exhaustive 
investigation into the specifics of conformation of the metal center and ligand 
environment during transmetallation, the scope of this study could only provide 
insight into the product yield outcomes relative to the variability in ligand 
characteristics. It was hypothesized, however, that certain ligands might enhance the 
rate of transmetallation by electronically or sterically stabilizing the transition state 
(Scheme 17).  
It was experimentally determined that ligands with a larger cone angle 
provided higher yields of allyl-aryl coupled products (P(o-tolyl)3 > PPh3), most likely 
due to the steric bulk of the ligand creating a π-allyl palladium complex with a low 
coordination number, thus expediting transmetallation of the aryl group from the 
activated silicate. While the ability to tune the coupled product yield through ligand 
modification was displayed, Pd(dba)2 still proved to be the most effective catalyst for 
our model coupling reaction. With this in mind, modification of the Pd(dba)2 alkene-
liganded catalyst model, to investigate their ability to be tuned and optimized, was 
envisaged. As was previously mentioned, Pd(dba)2 has a full compliment of 18 
electrons and no open coordination sites; its rate of catalytic action is based on the 
ability for ligand dissociation to occur to free up a coordination site. As such, it was 
posited that a certain class of triolefin palladium(0) catalysts, possessing only 16 
electrons and a free coordination site might improve the rate of transmetallation, and 
thus increase coupled product yield.  
It was believed that the ideal alkene ligands for our coupling methodology 




character that might slow ligand dissociation, and thus impede transmetallation. 
However, a balance must be found between the extremes of these characteristics, in 
order to provide a species that is reactive enough to expedite transmetallation, but 
also stable enough to not degrade before catalyzing the desired coupling. 
From a preliminary investigation into modified alkene-based palladium(0) 
catalysts, we have recently reported that the coupling of A-C ring analogues that had 
previously failed (Scheme 13), could now be achieved by employing Pd(COD)(NQ) 
as a catalyst (Scheme 19),55 producing a late-stage intermediate in the Hudlicky 























While successful in achieving the original goal of completing our formal total 
synthesis of (+)-7-deoxypancratistatin, the application of a new class of alkene 
catalysts now necessitated a more thorough, systematic evaluation to better 
understand the subtle effects modifying alkene ligands has on coupling yields (vide 




While a variety of tridentate, 16-electron Pd(0) complexes of this general 
structure have been reported in the literature (Figure 9),56-68 few studies of their 





























Roglans, 2010  
Figure 9. Alkene-based palladium(0) complexes 
 
In certain fused bicycles containing alkenes, the geometric configurations for 
optimal orbital overlap in the sp2-hybridized centers are unattainable, leading to 
marked energetic strain present in these ring structures. The relief of this ring strain is 
affected via rehybridization of the sp2 centers. The process of rehybridization is 
twofold.69 The electron density residing in the π orbital of the olefin ligand is donated 
into the vacant metal dσ orbital, further delocalizing the π electrons onto the metal 




donate electron density to the LUMO π* orbitals of both carbon centers in the olefin 
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Figure 10. π-back bonding, as it effects rehybridization of olefin ligands 
 
The binding of the ring-strained olefin ligands with the metal center of our catalysts 
should have an overall stabilizing effect, with their association effectively reducing 
the sp2 character of the geometrically constrained olefin to produce a more sp3-like 
carbon center, providing greater freedom in orbital overlap and relieving torsional 
strain. This relief in strain could be a major contributing force for the strong 
association we believe is present between our diene ligands and the metal center; the 
ligand-bound catalyst should be more energetically favorable than the free, ring-
strained ligand. 
The degree to which either of these modes of ligand binding occurs depends 
heavily on the nature of both the olefin and the metal. Electron rich, lower oxidation 
state metals allow for greater π back bonding, while higher oxidation state metals tend 




less π localized energy density present, so donation to the metal dσ is decreased. The 
precise degree to which electronics, ring-strain relief, ligand cone angle, and other 
factors affects the overall success of our catalysts remains to be seen. 
The purpose of this work was to systematically study the siloxane-based allyl-
aryl coupling technology previously developed in the DeShong group8,44,70 while 
employing a new class of tri-olefin liganded Pd(0) catalysts. 
 
Results and Discussion 
Based on the experience we have gained from our studies with pancratistatin 
analogues, the initial studies comparing the effectiveness of the 16-electron Pd(0) 
catalysts in the allyl-aryl coupling reaction were performed via the coupling of allyl 
carbonate 9 and aryl siloxane 7. It had previously been reported in the DeShong 
group that this coupling could be accomplished in good yield using the typical 18-
electron Pd(0) catalyst Pd(dba)2.8,44,51,70 The initial study was a comparison of 
Pd(dba)2 (I) and a series of  maleic anhydride 16-electron Pd(0) catalysts based on the 























Figure 11. Unsaturated cyclic anhydride and imide-based Pd(0) 16-electron 
complexes 
 
These complexes were chosen for investigation into their catalytic abilities in 
our allyl-aryl coupling reaction for numerous reasons. Several of these complexes had 
been previously reported by Itoh and Sakai, so their syntheses and characteristics 
were well known.56-58 Also reported, several catalysts selected possessed reasonable 
air and moisture stability for transition-metal complexes, circumventing the need for 
use of glovebox techniques, and allowing their creation in situ. Also, provided the 
variety of 16-electron palladium(0) complexes reported with similar structural motifs, 
the formation of new derivatives appeared attainable, thus allowing for a systematic 
investigation into the effects of modification of ligands on catalytic ability to be 




very little investigation into these species’ ability to catalyze coupling reactions had 
been reported to date, so this class of complexes was primed for deeper examination.  
Under a variety of reaction conditions, neither bis-alkene maleic anhydride 
complex II nor III was as effective as Pd(dba)2 (I) in catalyzing the allyl-aryl 
coupling reaction (Table 1). However, it is noteworthy that the norbornadiene 
complex III gave a higher yield of the coupled product than its cyclooctadiene (COD) 
analogue II (38% vs. 54%, respectively). Since the only difference between these two 
complexes was the cone angle associated with the diene ligands (norbornadiene and 
cyclooctadiene, respectively), it was concluded that the cone angle must have a 
significant effect on the stability or reactivity of the intermediate π-allyl complex in 
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Table 1. Synthesis of 3-phenylcyclohex-1-ene using unsaturated cyclic anhydride-
based Pd(0) 16-electron complexes.  
All reactions were performed at 55 oC for 24 h, using 2 equiv of TBAF.  





Itoh has also reported complex IV, in which maleic anhydride has been 
replace with tetracyanoethylene in the COD complex. However, Pd-complex IV was 
an ineffective coupling catalyst (Table 2), as we attribute the low yields in this case 
with the instability of the complex under the typical coupling conditions, with 
palladium black rapidly precipitating during the reaction. Analogous complexes V 
and VI were also prepared using the Itoh method, in which maleimide derivatives 
were substituted for maleic anhydride. The N-methyl maleimide complex V gave the 
best yield of the coupled product and demonstrated excellent stability under the 
coupling conditions. From these results, two major conclusions can be drawn: (1) 
norbornadiene (NBD) complexes give higher yields of the allyl-aryl coupling product 
than the complementary cyclooctadiene (COD) analogues (comparing the yields 
when using complex II vs. III, and the improved yields of the coupled product with 
complex V), and (2) the catalytic activity of the complexes can be “tuned” by 
modifying the electron-deficient alkene ligand (comparing the coupling yields for 
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Table 2. Synthesis of 3-phenylcyclohex-1-ene using unsaturated cyclic imide-based 
Pd(0) 16-electron complexes.  
All reactions were performed at 55 oC for 24 h, using 2 equiv of TBAF.  
*Yields represent isolated yields. 
 
As summarized above, it was concluded from the results in Tables 1 and 2 
that cone angle and/or the sterics of the bis-alkene ligands, norbornadiene or 
cyclooctadiene, play an important role in determining the catalytic activity of the 
Pd(0) complex. Alkenes, such as norbornene and norbornadiene, possess a high 




rehybridization, as well as a reduction of steric hindrance. Thus, the effective cone 
angle of the diene ligand can greatly affect the rate of coupling.71 The metal-alkene 
bond is described as a combination of σ-donation from a from a filled alkene π-orbital 
to an empty metal orbital, and π-back donation, from a filled metal orbital to an 
empty alkene π* orbital.53,71 For an electron rich d10-configuration metal such as 
Pd(0), π-back donation from the palladium center to the alkene is extremely important 
for stabilization. Stronger π-back donation results in a stronger palladium-alkene 
bond, thereby increasing the stability of the palladium complex, but reducing the 
lability of the alkene ligand and slowing transmetallation. 
While the reactions reported thus far were performed at 55 oC, it is important 
to note that both Pd(COD)(MAH) (II) and Pd(NBD)(MAH) (III) catalyzed the allyl-
aryl coupling reaction even at ambient temperature, which is not the case with 
Pd(dba)2, even though they provide lower yields of the coupling product. The 
decrease in yield can be attributed to instability of the 16-electron complexes in 
solution, compared to Pd(dba)2. As noted above, complex II rapidly decomposes to 
palladium black under the coupling conditions, while complex III is more stable. 
While the preparation of Pd(NBD)(MAH) (III) was trivial, the preparation of 
Pd(COD)(MAH) (II) and Pd(COD)(TCNE) (IV) (TCNE = tetracyanoethylene) was 
tedious and required careful handling due to their instability (precipitation of 
palladium black) when exposed to air at ambient temperature. Similarly, the 
incorporation of maleimides into the Pd(0) catalysts to give complexes V and VI, 





A comparison of the results in Tables 1 and 2 also demonstrates that the 
catalytic activity, as well as stability, of the metal-alkene complex can be “tuned” by 
adjusting the electronic properties of the electron-deficient ligand on the metal center. 
There are two possible explanations for the excellent yields of the NBD complexes 
III and V, respectively: (1) the NBD complexes have faster turnover rates than the 
other catalysts, or (2) the NBD complexes were more stable than the other catalysts. 
In the first scenario, if the rates of the catalytic cycle are faster for the NBD 
complexes, then more cycles can occur before the catalysts decompose, providing 
higher coupling yields. In the second case, if the catalysts are more stable, then more 
substrate could be processed before the catalysts decomposed, and higher yields of 
coupled product could be achieved. Without a complete mechanistic study of this 
coupling process, it is not possible to decipher the exact mode of increase in coupling 
product yield for this reaction. 
At this point, there are several mechanistic factors that require additional 
consideration: as shown in Scheme 20, NBD complex III presumably undergoes π-
allyl formation with concomitant loss of maleic anhydride to give complex A. 
Transmetallation of the aryl group from the silicate to palladium provides either 
complex B or C. Reductive elimination from B / C releases the coupled product and 
regenerates the catalyst. It is believed that the monodentate, electron deficient alkene 
is the ligand that initially departs to open a coordination site, as doping the coupling 
reaction with excess equivalents of this ligand increases the competition for binding 
at this site, and significantly decreases the coupled product yield (4 equiv. MAH 

































The short catalytic lifetime of the Itoh complexes II-VI limited their 
application in the allyl-aryl coupling reaction. Accordingly, the examination of 16-
electron Pd(0) complexes containing quinones was undertaken, as prepared from 



















Figure 12. Quinone-based Pd(0) 16-electron complexes 
 
These complexes are significantly more stable at ambient temperature, and 
therefore more readily prepared without resorting to glove box protocols. When 
employed in the allyl-aryl coupling reaction, Pd(COD)(NQ) (VII) gave superior 
yields in comparison to Pd(COD)(DQ) (VIII) and Pd(COD)(BQ) (IX), indicating a 
strong electronic influence in the catalysts’ performance. It is interesting to note that a 
subtle change, such as the inclusion of an aromatic ring from naphthoquinone (NQ) in 
the catalyst, dramatically improves the coupling yield compared to benzoquinone 
(BQ) and duroquinone (DQ). With duroquinone and benzoquinone acting as bidentate 
ligands, the palladium center has a full compliment of 18 electrons and no open 




dinuclear Pd(0) complex possessing BQ as a bidentate ligand and NBE (norbornene) 
as a monodentate ligand was also prepared,58 however this catalyst (X) provided a 
poor coupling yield (Table 3). Strangely, analogous complexes containing 
norbornadiene rather than cyclooctadiene proved too unstable to use for these 
coupling reactions, precipitating palladium black immediately upon formation. 
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Table 3. Synthesis of 3-phenylcyclohex-1-ene using quinone- 
based Pd(0) 16-electron complexes.  
All reactions were performed at 55 oC for 24 h, using 2 equiv of TBAF.  





While the use of chiral dienes as ligands in transition-metal mediated 
reactions is well established with other metals, specifically rhodium (Scheme 21),72 













dioxane / H2O (10/1)

















Given that the intermediate π-allyl complex derived from cyclohexenyl carbonate is a 
meso-compound (Scheme 22; when L* is achiral), the coupling reaction provided a 
racemic product. On the other hand, enantioenrichment of the coupled product should 
be possible if chirality can be imparted upon the intermediate (Scheme 22) by the 



















12   
 
By using (1R,4R)2,5-diphenylbicyclo[2.2.2]octa-2,5-diene (R,R-DPBCO), 
possessing C2 rotational symmetry, as a ligand in the preparation of the Itoh catalysts, 
the intermediate (12) prior to reductive elimination to provide the coupled product is 
chiral, and should favor formation of one enantiomer based on the sterics of the chiral 
ligand (Scheme 22). The enantiopurity of the starting cyclohexenyl carbonate should 
be immaterial, as upon leaving group displacement, the π-allyl complex is symmetric, 
and the stereochemistry of the final product is determined by the position from which 



















Racemic Mixture  
 
While the yield of coupled product using Pd(R,R-DPBCO)(MAH) as a catalyst was 
notable at 78%, no appreciable enantioenrichment (upper limit: >2% ee) was 
observed via chiral GC.  
The lack of enantioselectivity observed in the coupling reaction could stem 
from several sources. It was predicted that the chiral ligand statically associated with 
the palladium center in a bidentate fashion. If, however, the ligand rapidly 
interchanged between a bidentate and monodentate metal-binding motif, then the 
ability for chiral induction to be observed in the coupled product would be 
compromised, as the chiral environment ceases to exist when the ligand is associated 
to the metal center at only one position. Similarly, if the length of the coordinative 
bonds between the palladium center and the chiral diene present in intermediate 12 
are substantial, the ability for chiral induction to be observed in the coupling product 
may be limited, due to a decrease in the predicted steric interaction between the chiral 
ligand and the aryl moiety being added. Attempts at coupling more thoroughly 








In conclusion, a novel set of 16-electron palladium(0) complexes have been 
demonstrated to be catalytically active in the coupling of allyl carbonates and aryl 
siloxanes. In several instances, these complexes behaved comparable to the widely 
employed catalyst Pd(dba)2. While not requiring glovebox techniques, in situ 
generation of these catalysts was employed due to air and moisture stability issues. 
These complexes have also been demonstrated to possess “tunable” reactivity by two 
parameters: (1) the choice of diene ligand, which controls the cone angle of the 
alkene coordination, and (2) by adjusting the electronic characteristics of the electron-
deficient alkene attached to the metal center. The use of norbornadiene as the 
bidentate ligand in our complexes was shown to provide higher yields of coupled 
product, when compared to the implementation of cyclooctadiene. Similarly, N-
methylmaleimide was demonstrated to be superior to the other electron-deficient, 
monodentate alkene ligands surveyed. Finally, while providing good yields of 
racemic coupled product, attempts to employ a chiral class of these complexes for 







All reactions were performed under an atmosphere of argon unless otherwise 
noted. Glassware used in the reactions was dried for a minimum of 12 h in an oven at 
120 ºC and cooled in a dessicator prior to assembly. Tetrahydrofuran and diethyl 
ether were distilled from sodium / benzophenone ketyl, while methylene chloride, 
pyridine, and dimethylformamide were distilled from calcium hydride.  
Infrared spectra were recorded on a Nicolet 560 FT-IR spectrophotometer. 
Samples used for obtaining infrared spectra were either dissolved in carbon 
tetrachloride, taken neat, or obtained using the total attenuated reflectance adapter for 
solids. IR band positions are reported in reciprocal centimeters (cm-1) and relative 
intensities are listed as: br (broad), s (strong), m (medium), or w (weak).  
Nuclear magnetic resonance (1H, 13C, DEPT-135 NMR) spectra were 
recorded on a 400 or 500 MHz spectrometer. Chemical shifts are reported in parts per 
million (δ) and coupling (J values) are reported in hertz (Hz). Spin multiplicities are 
indicated by the following symbols: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br s (broad singlet), and br d (broad doublet). Low-resolution mass 
spectrometry (LRMS) and high-resolution mass spectrometry (HRMS) were obtained 











To 2.09 g (21.3 mmol) of 2-cyclohexen-1-ol, in 20 mL anhydrous CH2Cl2 and 2.6 mL 
(31.9 mmol) anhydrous pyridine, was added 3.2 mL (31.9 mmol) of ethyl 
chloroformate dropwise via syringe under argon. The reaction was allowed to stir at 
room temperature for 7 days. The completed reaction mixture was then extracted with 
CH2Cl2 (3 × 50 mL), and the combined organic layers were washed with H2O (50 
mL), dried over MgSO4 and concentrated in vacuo to give a slightly yellow, 
translucent oil. Flash chromatography on silica gel (5% EtOAc/95% hexane, Rf = 
0.51) afforded 2.32 g (64%) of 2-cyclohexenyl carbonate (9) as a colorless oil; IR 
(CCl4) 3042 (w), 2981 (w), 2947 (m), 2875 (w), 2838 (w), 1737 (s), 1373 (s), 1265 
(s), 1017 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 5.97-5.93 (m, 1H), 5.76- 5.73 (m, 
1H), 5.10-5.08 (m, 1H), 4.16 (q, J = 7 Hz, 2H), 2.09-2.04 (m, 1H), 1.99-1.84 (m, 1H), 
1.83-1.72 (m, 3H), 1.63-1.60 (m, 1H), 1.28 (t, J = 7 Hz, 3H); 13C NMR (100 MHz, 












To 50 mg (0.048 mmol) of Pd2dba3•CHCl3 in 1.5 mL of anhydrous acetone was added 
134 mg (1.45 mmol) of norbornadiene (bidentate ligand) and 27 mg (0.24 mmol) of 
N-methylmaleimide (monodentate ligand) under an atmosphere of argon. The 
reaction mixture was stirred for 30 minutes at room temperature, upon which 
noticeable palladium black had accumulated in the reaction vessel. The reaction 
mixture was transferred via cannula and filtered under argon to provide a translucent 
yellow-green solution. The solution was briefly concentrated in vacuo to provide a 
slightly more viscous, yellow-green oil, to which 5.0 mL of anhydrous diethyl ether 
was added. This provided an opaque, yellow-green suspension of Pd(NBD)(NMM) 
catalyst as a fine yellow powder, which was used immediately in the coupling 












To 30 mg (0.097 mmol) of Pd(NBD)(NMM) catalyst from the previous reaction, 
under an atmosphere of argon, was added 66 mg (0.39 mmol) of cyclohexenyl 
carbonate 9 and 186 mg (0.78 mmol) of phenyl triethoxysilane 7 in 5.0 mL of 
anhydrous THF. Immediately following the addition of the aryl siloxane, 0.78 mL 
(0.78 mmol) of 1 M TBAF solution in THF was introduced via syringe, and the 
reaction mixture was allowed to stir at 55 ºC for 24 h. Upon completion, the reaction 
mixture was cooled to room temperature, quenched with 10 mL of water, then 
extracted with Et2O (5 × 25 mL) and washed with 25 mL H2O. The combined organic 
layers were dried over MgSO4 and concentrated in vacuo to provide crude 3-
phenylcyclohex-1-ene (11) as a translucent, yellow oil. Purification by column 
chromatography (pentane; Rf = 0.65) provided 47 mg (77%) of racemic 3-
phenylcyclohex-1-ene (11), a known compound, as a colorless oil; IR (CCl4) 3025 
(s), 2934 (s), 2858 (m), 2838 (m), 1601 (w), 1492 (m), 1452 (m) cm-1; 1H NMR (400 
MHz, d6-benzene) δ 7.20-7.17 (m, 4H), 7.11-7.07 (m, 1H), 5.82-5.73 (m, 2H), 3.32-
3.27 (m, 1H), 1.92-1.89 (m, 3H), 1.56-1.47 (m, 3H); 13C NMR (125 MHz, d6-
benzene) δ 147.2, 131.0, 129.0, 128.8, 128.7, 128.5, 128.3, 126.7, 42.6, 33.4, 25.7, 
21.8. It is important to note that NMR characterizations were obtained in d6-benzene, 











Similarly to the specified general Pd(0) catalyst formation reported above, to 50 mg 
(0.048 mmol) of Pd2dba3•CHCl3 in 2.0 mL of anhydrous acetone was added 50 mg 
(0.19 mmol) of (1R,4R)2,5-diphenylbicyclo[2.2.2]octa-2,5-diene (bidentate ligand) 
and 19 mg (0.19 mmol) of maleic anhydride (monodentate ligand) under an 
atmosphere of argon. The burnt orange reaction mixture was stirred for 30 minutes at 
room temperature, upon which a small amount of palladium black had accumulated in 
the reaction vessel and the solution changed color to yellow-green. The reaction 
mixture was then transferred via cannula and filtered under argon to provide a 
translucent yellow-green solution. The solution was briefly concentrated in vacuo to 
provide a slightly more viscous, yellow-green oil, to which 5.0 mL of anhydrous 
diethyl ether was added. This provided an opaque, yellow-green suspension of 
Pd(R,R-DPBCO)(MAH) catalyst, which was used immediately in the chiral coupling 








Chiral 3-Phenylcyclohex-1-ene (11*) 
*
 
The known chiral compound 11* was formed using the same procedure reported 
above for the synthesis of racemic 3-phenylcyclohex-1-ene (11), with only scaling 
modifications being made. To 20 mg (0.043 mmol) of Pd(R,R-DPBCO)(MAH) 
catalyst from the previous reaction, under an atmosphere of argon, was added 29 mg 
(0.17 mmol) of cyclohexenyl carbonate 9 and 83 mg (0.35 mmol) of phenyl 
triethoxysilane 7 in 4.0 mL of anhydrous THF. Immediately following the addition of 
the aryl siloxane, 0.35 mL (0.35 mmol) of 1 M TBAF solution in THF was introduced 
via syringe, and the purple reaction mixture was allowed to stir at 55 ºC for 24 h. 
Upon completion, the reaction mixture was cooled to room temperature, quenched 
with 10 mL of water, then extracted with Et2O (5 × 25 mL) and washed with 25 mL 
H2O. The combined organic layers were dried over MgSO4 and concentrated in vacuo 
to provide crude chiral 3-phenylcyclohex-1-ene (11*) as a translucent, yellow oil. 
Purification by column chromatography (pentane; Rf = 0.65) gave 21 mg (78%) of 
chiral 3-phenylcyclohex-1-ene (11*) as a colorless oil; IR, 1H and 13C NMR matched 
the spectra obtained for racemic 3-phenylcyclohex-1-ene (11) vide supra. It is 
important to note that NMR characterizations were obtained in d6-benzene, to avoid 
potential double bond isomerization catalyzed by acid impurities in CDCl3. Indication 




chiral gas chromatography. Using the following chiral gas chromatography 
parameters as employed by Andersson and coworkers,51 the (+)-R enantiomer is 
reported as having a retention time of 53.80 minutes, while the (-)-S enantiomer has a 
retention time of 54.40 minutes. Chiral gas chromatography of our chiral coupling 
product 11* was accomplished using an Astec CHIRALDEX B-DM GC column 
(30m long x 0.25mm diameter). The helium carrier gas flow rate was set to 1 
mL/min, with the injector temperature set to 200 oC. The initial column temperature 
was 70 oC (held for 10 minutes), with a temperature ramp of 1 oC/min until a final 
temperature of 160 oC was reached (held for 150 minutes). Poor resolution of 
enantiomers prevented the precise indication of degree of enantioenrichment in our 
final coupling product (Figure 13), but visual inspection of the chromatogram 




Figure 13. Chiral gas chromatogram of allyl-aryl cross-coupling product 3-






Synthetic Approaches Toward the Pyridyl C-Ring of the 
Aminoquinone Natural Product Streptonigrin  
 
Introduction 
Streptonigrin and Analogues 
Several metabolites of soil-dwelling bacteria of the genus Streptomyces, 
particularly the aminoquinone containing natural products streptonigrin (13) and 
lavendamycin (14), possess marked antitumor, antiviral, and antimicrobial 
characteristics (Figure 14). Isolated by Rao and colleagues from the bacterium 
Streptomyces flocculus in 1959,74 streptonigrin displays remarkable chemotherapeutic 
abilities against various types of cancer, including lymphoma, melanoma, breast, 
lung, head, and neck.75 Similarly, lavendamycin, isolated from the bacterium 
Streptomyces lavendulae in 1981 by Doyle and coworkers,76 possesses antibacterial 
(strep and staph), antifungal (athlete’s foot, yeast, and ringworm),77 antitumor 


































Figure 14. Structure of Streptomyces alkaloids 
 
The main structural discrepancy between these two metabolites is the presence 
of the D-ring pyrrole fusion in lavendamycin (14), creating a CDE-carbazole moiety, 
which falls coplanar with the AB-quinolinequinone fused-ring system. The absence 
of CDE-ring system fusion in streptonigrin (13) allows for the C- and D- rings to 
offset from each other. X-ray studies of the natural product have determined the C- 
and D- rings are nearly orthogonally oriented.81 While this deflection from 
coplanarity allows for the circumvention of steric interactions between the C-ring 5-
position methyl group and the D-ring 2-position hydroxyl functionality, free rotation 
about the CD- ring junction bond is impeded by the same interactions, leading to 



































Figure 15. Atropisomerism in streptonigrin arising from CD- ring system deflection 
 
Despite the absence of classic tetracoordinated, sp3 stereocenters in the natural 
product, streptonigrin (13) is optically active, possessing axial chirality.82 Naturally 
isolated streptonigrin has been determined to occur in the M / Ra orientation, via 
exciton coupled circular dichroism spectroscopy.83 The non-coplanarity of the CD- 
ring system hinders synthetic access via coupling methodologies, given the steric 
encumbrance experienced by the transmetallated intermediate in attempting to orient 
properly for reductive elimination. 
Derivative studies have shown that the pharmacophoric region leading to the 
cytotoxic and antimicrobial characteristics of streptonigrin and lavendamycin is their 
substituted quinoline-5,8-quinone AB-ring systems.84,85 Derivatives of the AB-ring 
system of lavendamycin, including an isopropylaza functional group substituted at the 
7- and 8-positions,86 as well as hydroxyl and methoxy groups replacing the amine 
group at the 7-postion,87 have displayed limited activity as anticancer agents. 
The precise mechanism of streptonigrin and lavendamycin’s biological 




structural differences between the CD- and CDE- ring systems of these natural 
products, the proposed route of action in biological systems should be consistent, as 
their AB-ring system active sites are remarkably similar.  
The mode of the cellular toxicity of streptonigrin and lavendamycin has been 
linked to various processes: the depletion of the biological reducing agents NADH 
and NADPH, the inhibition of enzymes which promote the transfer of electrons in the 
inner mitochondrial membrane, the bypassing of oxidative phosphorylation, the 
depletion of cellular ATP, an irreversible binding to the minor groove of DNA and 
the direct insertion of the ring systems in between the base-pair hydrogen bonds, and 
the quinone moiety’s propensity for the formation of radicals, which lead to single-
strand breaks in DNA, have all be proposed.84  
The structure of the AB-ring systems of streptonigrin and lavendamycin, as 
well as the free rotation of the bond between the AB- and C-ring systems, also make 
these compounds functional chelating agents for polyvalent metal cations. The 
presence of an M2+ cation, which can be chelated by both natural products (Figure 
16), makes the quinone moiety more reactive toward reduction by NADPH and 
































The enzymatic reduction of streptonigrin by one electron, to form a semiquinone 
radical (Figure 16), or two electrons, to form hydroquinone, often leads to the 
production of free hydroxyl and superoxide radicals via auto-oxidation with oxygen 
gas, which can in turn cause significant damage to DNA.89 This auto-oxidation occurs 
outside the pathway of oxidative phosphorylation, thereby obliquely decreasing 
cellular ATP counts as well.84 
Further preclinical studies of streptonigrin have proven its toxicity to be rather 
indiscriminant, in that it kills both cancerous and healthy cells.75,79,84 Due to poor 
solubility in aqueous systems and most organic solvents, streptonigrin has also proven 
difficult to administer. These, along with other problems, have prevented the drug 
from proceeding past phase II clinical trials, which were ended in 1977.90 However, 
streptonigrin’s marked antibiotic and antitumor capabilities supported further research 
into its pharmaceutical potential. With a general knowledge of the active 
pharmacophoric region of the molecule, rational modifications to the compound 
could be designed in order to attempt to temper the deleterious side effects while 
maintaining desired ones. Due to low-occurring natural yields of streptonigrin,91 
synthetic approaches were undertaken to produce the natural product in a concise 
fashion, in high yields, so that the formation of new analogs for clinical testing could 





Synthetic Approaches Toward Streptonigrin 
While several syntheses of lavendamycin have been reported,92-98 the 
remainder of this discussion will focus on work relating to streptonigrin. To date, the 
fully functionalized tetracyclic structure of streptonigrin (13) has only been 
synthesized four times in the literature: by Weinreb’s group,99 Kende’s group,100 
Boger’s group,101 and Donohoe’s group.102 We will focus the majority of our 
discussion on the creation of the C-ring in these syntheses. 
 The first total synthesis of streptonigrin, completed by Weinreb in 1980, is 























































The poor regioselectivity and yield of this reaction, provided the nearly identical 
molecular-orbital energy coefficients in the diene, and the overall length of Weinreb’s 
total synthesis (34 steps) hinders the practicality of its application in access to 
streptonigrin. 
Kende’s synthesis, completed in 1981, was notable for the relative economy 
of steps taken to attain the core structure of streptonigrin (27 steps). Final yields, 

































While quickly accessing the CD-ring backbone in excellent yield via condensation, 
problems arise with Kende’s approach to streptonigrin upon completion of the total 
skeleton of the natural product, when 11 subsequent steps must be undertaken to get 
to the desired advanced intermediate. Kende’s synthetic approach of forming the 
carbon backbone first and then functionalizing largely precluded subsequent 
opportunities for the formation of functional analogues without major modifications 
and planning, limiting its applicability toward future pharmaceutical derivation. The 
formation of the pyridone C-ring precursor via condensation proved intriguing, 




 Two years later, in 1983, Boger reported his total synthesis of streptonigrin. 
Similar to Weinreb’s synthesis, Boger approached the tetracyclic system through a set 
of Diels-Alder cycloadditions. By employing a symmetric tetrazine as the diene in the 
first cycloaddition, Boger ensured only one possible regioisomeric product would be 























































However, the regioselectivity of the second cycloaddition could not be guaranteed, 
and a 2.8 : 1 mixture of desired product A to side product B was obtained. Once 
again, the issue of regioselectivity in forming late-stage intermediates limits the 
applicability of Boger’s synthesis. However, Boger’s synthesis is notable, given the 
fact that the AB-ring system of streptonigrin is initially constructed in near entirety, 
with a dieneophilic moiety attached for subsequent cycloadditions. This affords the 
opportunity to make AB-ring modifications prior to the formation of the CD-ring 




The most recent synthesis of streptonigrin was completed by Donohoe in 
2011, and implements many of the concepts of modularity for derivatization we aim 
to highlight herein.102 Through the employment of Grubbs-Hoveyda second-
generation metathesis catalyst, Donohoe was able to affect the ring closure of a C-
ring intermediate from a branched, functionalized amide and an α,β-unsaturated 




























By installing two varied coupling points in his C-ring intermediate, a triflate and a 
bromide group, Donohoe was able to selectively couple his AB- and D-ring systems 
to complete the skeleton of streptonigrin. Unfortunately, for reasons mentioned earlier 
in this manuscript, Donohoe’s selection of Stille’s tin-based coupling for the 
attachment of his AB- and C-ring precursors will prove problematic if biological 
studies of his synthetic products are to be undertaken. 
Ideally, the synthesis of streptonigrin would be completed modularly, with the 
different ring segments being functionalized separately and then brought together at 
the end to yield the desired product. This route would offer greater freedom of variety 




chemical transformations of substituents in larger systems, as was a concern in many 
of the previous syntheses. With great strides made in the field of cross-coupling 
technology since Boger’s synthesis in 1983, the application of such technology to the 
synthesis of streptonigrin seemed a promising area of research. Therefore, studies on 
the modular total synthesis of streptonigrin were begun in the DeShong group. 
 
Synthetic Approaches Toward Streptonigrin in the DeShong Group 
 The implementation of siloxane-based coupling technology developed in the 
DeShong group was envisioned for the modular total synthesis of streptonigrin and 
subsequent analogues.103-106 Unfortunately, the ring precursors of streptonigrin 
developed by McElroy and Sandelier were not amenable to siloxane coupling, so 
other modes of ring attachment needed to be designed.107 It was ultimately settled that 
Sonogashira and Suzuki couplings would be used in our proposed total synthesis of 

























































Figure 17. Proposed retrosynthesis of streptonigrin 
 
While the development of CD-ring Suzuki coupling103 and AB-ring reductive 
cyclization105 were undertaken separately, efforts at coupling analogues of the AB-
ring system to McElroy’s biaryl CD-ring intermediate,104 and C-ring analogues of to 
Sandelier’s bicyclic AB-ring precursor,106 proved problematic. 
 In order to better examine the shortcomings in Sandelier’s Sonogashira 
coupling and subsequent reductive cyclization to provide substituted quinolines for 
our proposed synthesis, I was tasked with producing sufficient quantities of pyridyl 
C-ring precursors and analogues, while also addressing some of the deficiencies 
observed in McElroy’s reported synthesis. 
 Upon examination of the first section of McElroy’s C-ring synthesis (Scheme 
28), one can see that the functionalization, rather than ring assembly, posed the most 























































Amination of ethyl-2-methylacetoacetate (15) on a clay substrate, followed by diethyl 
malonate condensation to provide hydroxypyridone ethyl ester (17) proceeded 
unremarkably and in good yields. Subsequent decarboxylation occurred nearly 
quantitatively to provide hydroxypyridone 18. Issues began to arise, however, upon 
attempted bromination using phosphorus oxytribromide. In order to improve the CD-
ring synthesis, I began work toward the optimization of the bromination of 
hydroxypyridone intermediate 18. 
 Similarly, the later portion of the McElroy pyridyl C-ring synthesis proceeded 
relatively expeditiously, containing transformations that predominantly proceed in 






















































Interestingly, bromomethoxypyridine 20 was oxidized to the N-oxide, which was 
subsequently captured by acetate, rearranged, and hydrolyzed to provide pyridyl 
alcohol 21 (Scheme 30, redrawn from reference 104). This pyridyl alcohol was then 
methylated to protect during mixed acid nitration, then demethylated, oxidized, and 
esterified to provide the completed C-ring intermediate 24. 
 
Scheme 30 


















While conceptually reasonable, the number of steps undertaken in order to 
functionalize the 6-position methyl group, including protection and deprotection, 
added to the overall length of the synthesis and diminished total product yield. To 
further improve on McElroy’s CD-ring synthesis, I also focused on streamlining some 
of the late stage modifications, to minimize the number of steps and avoid loss in total 
product yield.  
With the moderate length of this synthesis, numbering 14 linear steps, 3.8% 
product yield is a reasonable figure. By undertaking the modifications previously 
mentioned, it was hoped that further improvement could be made. 
The purpose of this work was to improve upon problematic portions of our 
previously reported synthesis of streptonigrin’s pyridyl C-ring,103 particularly 
regarding the 4-position bromination and 6-position oxidation, to provide higher 
yields of key intermediates and to improve overall economy of steps. 
 
Results and Discussion 
Selective bromination at the 4-position of hydroxypyridone 18 is vital for the 
subsequent Suzuki coupling with the D-ring aryl boronic acid intermediate in latter 
steps of the synthesis. Solubility and polarity issues precluded the chromatographic 
purification of many synthetic intermediates from impurities, particularly the 
brominated products. This being the case, crude products from several steps were 




intermediate 18 for study proceeded without note, all providing within 15% of 
McElroy’s reported yields. 
The brominating agent chosen by McElroy, phosphorus oxytribromide, is a 
markedly air sensitive solid at room temperature, which readily degrades to provide 
phosphoric acid in the presence of water, so the utmost care must be taken during its 
delivery to the reaction. Furthermore, each equivalent of brominating agent had the 
ability to donate 3 equivalents of bromide, so care must be taken to avoid 
overbromination. While monobrominated product 19 normally predominated, the 
formation dibromopyridine 25 also was observed via NMR (Scheme 31). All yields 




















It appears that solubility was a key issue in the low yields of this reaction. The 
bromination method chosen by McElroy utilized 0.67 equivalents of phosphorus 
oxytribromide in N,N-dimethylformamide to selectively provide 62% yield of the 
monobromopyridone 19 intermediate. Attempts to duplicate the reaction under the 
described conditions, however, only resulted in 35% yield of 19. Given that the 
product’s high solubility in the extremely polar DMF solvent may have led to an 




to solubilize the starting material was attempted as well. Unfortunately, similarly low 
yields were observed when under these minimal solvent conditions. 
Following our planned reduction in solvent usage, alternative reagents for 
bromination were also examined, particularly phosphorous tribromide (a liquid at 
room temperature), for their efficacy in affecting bromination under solvent-free 
conditions. Results from bromination via PBr3 were mixed. 
The neat bromination of hydroxypyridone 18 with phosphorus tribromide 
proceeded relatively unremarkably. Similarly to the McElroy bromination, upon 
completion of the reaction, quenching with water, and basifying the solution with 
sodium carbonate, the yellow product precipitated from solution giving 
approximately 43% yield. Given that the reaction was being run neat in PBr3, a 
greater number of equivalents of brominating reagent were employed (~2 eq) to 
ensure adequate solvation, compared to McElroy’s bromination with POBr3 in DMF. 
However, the initial neat reaction only yielded a 2 : 1 monobrominated (19) to 
dibrominated (25) product ratio.  
Testing the limits of the reaction selectivity, the number of equivalents of 
PBr3 was increased by an order of magnitude, to see the effect it would have on 
product distribution. Interestingly, the significant increase in amount of brominating 
reagent used had a twofold effect: (1) the ratio of monobrominated (19) to 
dibrominated (25) product flipped to 2 : 3, now favoring multiple brominations, and 









19:25  2 : 1
PBr3 (30 eq)
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One of the major hypothesized avenues that we believe is affecting our yields 
is the formation of highly water-soluble phosphate esters—intermediate species in the 
bromination process that ultimately fail to react further to provide the desired 
products (Figure 18). This follows logically with both observations previously stated: 
that the more equivalents of brominating reagent present in the reaction mixture, the 
lower the observed yields tend to be, and for the products that do form, multiple 
brominations are favored. With more equivalents of reactive PBr3 present in solution, 
the opportunity to phosphorylate all oxygen species increases as well. Whether these 
remain as phosphate esters or are displaced by bromide to provide the desired 

















X = -Br, -OR  





With this in mind, we attempted to examine the phosphate’s ability to promote 
coupling to the 2- or 4-position using nothing more than an in situ formed 





































Great care was required in order to avoid quenching from the introduction of moisture 
to either the acetylide or the pyridine phosphate ester reaction vessels. Unfortunately, 
even by employing cannula transfer techniques and various solvents, only quenched 
starting materials were observed upon the completion of the reaction. The phenyl 
acetylide most likely acted more as a strong base than as a nucleophile, with various, 




Provided the shortcomings of the direct phosphate coupling of the model A-
ring, examination of the Sonogashira coupling with our brominated products was 
begun next. In our proposed retrosynthesis of streptonigrin (Figure 17), we 
envisioned the completed C-ring intermediate undergoing Sonogashira coupling with 
an o-nitro propargyl alcohol A-ring precursor at the C-ring’s 2-position triflate 
moiety. It has been previously reported that electron-poor halogen-carbon bonds 
facilitate Sonogashira coupling reactions. Iodides, triflates, and bromides, for 
example, react markedly better than chlorides, and vinyl halides provide greater 
coupling than aryl halides.108 These tendencies have been exploited by various groups 
to provide selectivity in the coupling of non-symmetric dihalogenated systems, 
namely employing both iodide and bromide in the same system while limiting the 
number of equivalents of alkyne, so that only the iodide center will couple.109 
Similarly, electronic manipulations to different coupling centers baring the same 
halogen have been examined for several different dihaloheterocycles, including 2,4-
dibromoquinoline,110 pyrimidine,111 and 2,5-dibromopyridine.112  
Most relevant to our synthesis, however, is the work published on the 
stereoselective synthesis of the visual pigment A2E, in which 2,4-dibromopyridine 
underwent a selective Suzuki coupling at the 2-position, followed by subsequent 
Sonogashira coupling at the 4-position.113 All things being equal, the electronically 
deficient nature of the carbon-halogen bond adjacent to the heteroatom in the ring 
usually directs the coupling reaction to the 2-position over others, when coupling 




formation of the desired 2-alkynyl-4-bromopyridine (26A), the Sonogashira coupling 












































26C 26D  
  
The use of preferential coupling would be the ideal arrangement for our 
desired total synthesis, however the issue of mixtures of bromination products 
prevents this from being realized. As mentioned above, the direct separation of 
monobromopyridone 19 from dibromopyridine 25 has proven problematic, so a 2:1 
mixture of starting materials was used in these studies. With three possible coupling 
locations available, and the potential for four different coupling products, it was 
apparent that the varying electronic characteristics of the different coupling partners 
and coupling centers would determine what, if any, regioselectivity was to be 
achieved. 
By adding only 0.5 equivalents of phenylacetylene, we attempted to prevent 




inclinations of the Sonogashira coupling for our intermediate. One of the major 
difficulties in our method, however, was the sheer complexity of the potential final 
coupled products that it yielded. With four potential products and three starting 
materials mixed in our final yield, chromatographic separation of the mixture would 
be of paramount importance in determining what reactivity, if any, had predominated. 
While trace unreacted phenylacetylene and various other uncoupled side-
products were flushed from the product mixture, what appeared to be our coupled 
targets remained at baseline. Another issue that arose during the investigation of the 
coupled system mix was the proper selection of analysis method. Given the lack of 
proton-carbon correlation across the 4-carbon bridge formed during the coupling 
reaction, direct 1H, 13C, or correlated spectroscopy provide no regio- information, 
only that it did occur. We decided to investigate through-space, proximity magnetic 
relaxation via NOESY experiments. Given the probable orthogonal configuration of 
the coupled ring to the pyridine / pyridone C-ring, and the relatively long-range from 
the A / A’ position protons on the coupled ring to the 5-position methyl of the 
pyridine / pyridone C-ring, we were concerned that we may not be able to detect NOE 














Similarly, our spectroscopic results would most likely only indicate if coupling had 
occurred at the 4-position, as the 2-position doesn’t offer suitably large neighboring 
groups for long distance relaxation to be observe. 
A selective NOE experiment was chosen over 2D-NOESY, given the high 
complexity displayed in the aromatic region of the 1H NMR. In each experiment, 
what was deemed the A/A’ proton on the aromatic coupling partner was selectively 
pulsed to search for the presence of spatially neighboring groups on the pyridine / 
pyridone. While most of the NMR experiments provided no NOE signals, two of the 
peaks pulsed did show correlation to peaks in the methyl group range of our pyridine 
/ pyridone, signifying coupling to the 4-position of our C-ring intermediate. 
While the direct ratio of coupled products 26A-D is still indeterminate, these 
results are promising, given that the coupling product at the 4-position was expected 
to be minor. However, until a direct measurement of the 2-ethynyl-4-bromopyridine 
coupling product (26a) can be made, no specific claims regarding the regioselectivity 
of the coupling reaction can be made. In order to improve this experiment, pure 
starting materials should be used. We could then determine the degree of conversion 
of starting material to some form of product, directly measure those coupling 
products at the 4-position via NOESY, and then infer the remaining percentage of 
other coupling partners based on the side product and 4-position coupling partner 
yields. Similarly, a better choice of coupling partner for our pyridine / pyridone 
system could be made while remaining true to the A-ring precursor after which it 




phenyl ring, a greater NOE might be observed, potentially allowing for direct 
identification and measurement of coupling occurring at the 2-position of the C-ring. 
This would make the analysis of the regioselectivity of the Sonogashira coupling with 
our C-ring intermediate significantly easier. 
Similar work was also undertaken for the study of modifications to other parts 
of our C-ring precursor, as well. Provided the relative success of our early-stage 
amination and condensation reactions for the standard C-ring precursor system 
(Scheme 28), attempts were made to modify the starting materials being aminated or 
condensed, in order to impart desired functionality onto our ring system immediately 









































































Initially, attempts to annulate a C-ring precursor analogue by replacing the standard 
diethylmalonate substrate with ethyl nitroacetate (27) were begun. The proposed 
product (28) this modification would generate would possess the desired 3-position 
nitration, saving us subsequent steps. Possessing highly acidic protons alpha to both 
the nitro and ethyl acetate groups when compared with those in diethylmalonate, 
ethyl nitroacetate should readily provide a nitronate substrate under the conditions 
employed, which we believed would undergo ring annulation expeditiously in the 
presence of aminated substrate 16. A disappointing lack of desired product 28 was 
observed however, causing us to ultimately abandon this route. 
 Similarly, the implementation of diethyl oxalpropionate (29) as an amination 
substrate was investigated. Amination should proceed selectively at the ketone 
position of oxalpropionate 29, providing us with enamine product 30. This can be 
envisaged to undergo ring annulation with diethyl malonate to provide C-ring 
precursor analogue 31, possessing an ethyl ester in the 6-position which otherwise 
would require several subsequent steps to install in our originally proposed synthesis. 
Unfortunately however, aminated product 30 was never realized. 
 Modifications to later stages of our C-ring precursor were also attempted, to 
interesting result. The use of diethyl malonate to produce hydroxypyridone ethyl ester 
17, with concomitant decarboxylation at the 3-position appeared atom-uneconomical. 
By removing functionality at a position that would eventually require 
refunctionalization, it appeared we were adding more steps to our overall synthesis. 




attempts were made at utilizing the ethyl ester intermediate functionality at the 3-




































McElroy reported that, upon treatment of hydroxypyridone ethyl ester 17 with POBr3, 
dibromopyridine acid bromide 32 was produced in 58% yield. It was planned that, 
upon addition of an azide source to the activated acid bromide, acyl azide 33 would 
be produced, which, under Curtius conditions, would rearrange to yield 
dibromoaminopyridine 34. Unfortunately, attempts to affect the formation of 
dibromopyridine acid bromide 32 via treatment of hydroxypyridone ethyl ester 17 
with PBr3 proved unfruitful. Rather, the isolated product of this transformation was 
bromopyridone carboxylic acid 35, potentially arising from the hydrolysis of and acyl 
bromide intermediate upon bromination quenching and workup with water. While an 
interesting and unexpected product, subsequent transformations of the bromopyridone 




 The final major C-ring synthetic modification of interest examined was the 
attempted application of the Coe methodology for the formation of aldehydes from 



















The Coe methodology offers a facile route to the desired aldehyde moiety present in 
the C-ring intermediate, which can undergo subsequent oxidation and esterification to 
provide the desired functionality at the 6-position. This reaction was undertaken with 















































Provided the strongly electron-deficient character of both of these starting materials, 
they are perfect candidates for the Coe reaction, which proceeded without issue. With 
the inductive withdrawing effects of the bromine atoms at the 4-, or 2- and 4-
positions, along with the resonance stabilizing effects also provided from the 
pyridone carbonyl, we expect that the 6-position methyl group on the rings will be 
more electron deficient than the 5-position, making the 6-position methyl more likely 
to undergo the formation of desired enamines 36 and 37. Sodium periodate cleavage 
yielded monobromopyridone carboxyaldehyde 38 and dibromopyridine 
carboxyaldehyde 39 in 29% yield for the two steps, in a 10:1 ratio, respectively, 
based on 1H NMR. The purification process via flash chromatography is once again 
an issue with this system, so a viable mode of separation must be determined or pure 
starting materials should be used. While these findings are notable, as they help to 
streamline the conclusion of the C-ring synthesis, yield improvements must be made 
in order for this to supplant our current synthetic methodology. 
 Introducing an electron-withdrawing aldehyde group would further activate 
the C-ring intermediate toward nucleophilic additions, so attempts were made at 
introducing the Coe methodology earlier in our C-ring synthesis. Unfortunately, it 
appears that the presence of any particularly acidic protons quenches the methoxide 




















Figure 20. Proposed structure of amine mixed acetal byproducts of 17 and 18 
 
Desired aldehyde product from the Coe methodology was only observed when the 4-
position hydroxyl group had been brominated. This follows logically, as the 4-
position hydroxyl group is vinylogous to the pyridone carbonyl, thereby stabilizing 
the conjugate base via resonance and lowering the expected pKa of the hydroxyl 


















 In conclusion, investigation into modifications of McElroy’s C-ring synthesis 
has been completed. While resulting product yields fall below expectations due to 
solubility and impurity issues, interesting findings regarding bromination, 
intermediate couplings, and the application of Coe methodology have been reported. 
Development of new purification techniques would be paramount to the future 







All reactions were performed under an atmosphere of argon unless otherwise 
noted. Glassware used in the reactions was dried for a minimum of 12 h in an oven at 
120 ºC and cooled in a dessicator prior to assembly. Tetrahydrofuran and diethyl 
ether were distilled from sodium / benzophenone ketyl, while methylene chloride, 
pyridine, and dimethylformamide were distilled from calcium hydride.  
Infrared spectra were recorded on a Nicolet 560 FT-IR spectrophotometer. 
Samples used for obtaining infrared spectra were either dissolved in carbon 
tetrachloride, taken neat, or obtained using the total attenuated reflectance adapter for 
solids. IR band positions are reported in reciprocal centimeters (cm-1) and relative 
intensities are listed as: br (broad), s (strong), m (medium), or w (weak).  
Nuclear magnetic resonance (1H, 13C, DEPT-135 NMR) spectra were 
recorded on a 400 or 500 MHz spectrometer. Chemical shifts are reported in parts per 
million (δ) and coupling (J values) are reported in hertz (Hz). Spin multiplicities are 
indicated by the following symbols: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br s (broad singlet), and br d (broad doublet). Low-resolution mass 
spectrometry (LRMS) and high-resolution mass spectrometry (HRMS) were obtained 















This reaction was not performed under inert atmosphere. Ethyl 2-methylacetoacetate 
(50 g, 0.35 mol) was absorbed onto 75 g of montmorillonite K-10 clay. To the 
viscous clay suspension, 43 mL (0.65 mol) of 14.9 M ammonium hydroxide were 
added, and the resulting mixture was stirred for 24 h at room temperature. Upon 
completion, the clay was washed 4x with 300 mL aliquots of methylene chloride, and 
the combined organic washings were dried over MgSO4. The dried washings were 
then concentrated in vacuo to yield 39.8 g (80%) of α, β-unsaturated amino ester 
product 16 as slightly yellow, crystalline plates. No purification of the product was 
necessary. Spectral data correspond to that reported by McElroy.104 
 







Sodium ethoxide solution was prepared by adding 1.7 g (74 mmol) of sodium metal 
to 29.0 mL of anhydrous ethanol. To this solution was added a mixture of 10.5 mL 
(69 mmol) of diethyl malonate in 4.0 mL of toluene. The resulting solution was 
stirred at room temperature for 1 h. A solution of 5.0 g (35 mmol) of α, β-unsaturated 
amino ester 16 in 11.0 mL of toluene was then added, and the resulting mixture was 




min. The phases were separated and the aqueous layer was washed with toluene. The 
aqueous layer was then concentrated in vacuo to remove ethanol, then acidified with 
concentrated HCl to yield precipitate. The precipitate thus obtained was filtered, 
washed with water, and dried to yield 4.3 g (59%) of hydroxypyridone ethyl ester 17 
as an off-white powder. No further purification of the product was necessary. Spectral 







A solution of 3.0 g (14 mmol) of hydroxypyridone ethyl ester 17 and 5.4 g (0.13 
moles) of NaOH in 65.0 mL of water was heated at reflux for 2 h. The solution was 
then cooled to 0 oC, brought to pH = 7 with concentrated HCl, and stirred at room 
temperature for 12 h. The precipitate thus obtained was filtered and washed with 
water to yield 1.7 g (87%) of the white solid hydroxypyridone 18. No further 





















A mixture of 50 mg (0.36 mmol) of hydroxypyridone 18 and 1.0 mL (2.87 g, 10.6 
mmol) of PBr3 was heated at 140 oC for 4 h. During the course of the reaction, any 
solid that was deposited on the sides of the vessel was scraped back in to the mixture. 
Upon completion, the solution was allowed to cool to room temperature, and then ice 
water was added dropwise. The quenched solution was then allowed to stand 
overnight, upon which time a yellow-orange powder had precipitated. The suspension 
was then brought to pH = 7 with NaHCO3, which provided an opaque, tan solution. 
This mixture was transferred to a centrifuge tube and spun down to provide a tan-
orange pellet. The supernatant was decanted off, and the pellet was resuspended with 
distilled water. This mixture was then spun down again, to remove any remaining 
NaHCO3, and the supernatant was again removed. The pellet was left exposed to the 
atmosphere to allow for moisture to evaporate overnight. The pellet yielded 18 mg 
(19%) of mostly dibromopyridine 25 as an orange-brown powder. To attempt an acid-
base extraction, the combined aqueous supernatants were then reacidified with 
hydrochloric acid and extracted with methylene chloride. The organic phase was then 
removed and discarded, and the aqueous phase was neutralized with sodium 
hydroxide. Upon neutralization, the aqueous phase was extracted 3x with 15 mL of 
methylene chloride, and the combined organic layers were dried over MgSO4. The 




mixture of monobromopyridone 19 and dibromopyridine 25 as a tan powder. Spectral 
data for these products coincide with that reported by McElroy.104 
 
Phosphate Coupling Procedure 
A mixture of 0.41 g (2.96 mmol) of hydroxypyridone 18 and 1.76 g (6.51 mmol) of 
PBr3 was heated at 110 oC for 1 h under inert atmosphere and stirring. Upon 
completion and cooling, 10 mL of anhydrous THF was added to increase the slurry 
volume. At the same time, a solution of 0.92 g (9.62 mmol) of phenylacetylene in 15 
mL of anhydrous THF was cooled to 0 oC under inert atmosphere. To this solution, 
0.47 g (7.40 mmol) of 2.5 M n-butyllithium was added dropwise via syringe, and the 
resulting mixture was stirred for 30 min at 0 oC. The bromination slurry was then 
added to the phenylacetylide solution via cannula. The mixture was stirred at 0 oC for 
1h, then quenched with water. THF was removed in vacuo, and then the aqueous 
layer was extract 3x with 30 mL of diethyl ether. The combined organic layers were 
dried over MgSO4, and then concentrated in vacuo to yield 0.75 g of crude product 
mixture as an orange oil. Column chromatography (7:3 hexanes:ethyl acetate) eluted 
0.493 g of pure phenylacetylene (1H NMR (CDCl3) δ 3.09 (s, 1H), 7.36 (m, J = 2, 6 
Hz, 3H), 7.57 (d, J = 4 Hz, 2 H)) and 0.072 g of an unidentified side product (1H 
NMR (CDCl3) δ 1.74 (m, J = 4 Hz, 2H), 1.97 (m, J = 4 Hz, 2H), 3.46 (t, J = 8 Hz, 
2H), 3.71 (t, J = 8 Hz, 2H)). A methanol flush of the column provided 0.171 g of 
























Ph Ph  
A solution of 100 mg (0.45 mmol) of a 2:1 mixture of monobromopyridone 19 and 
dibromopyridine 25, 23 mg (0.23 mmol) of phenylacetylene, 10 mg (0.009 mmol) of 
tetrakistriphenylphosphine palladium(0), 2 mg (0.009 mmol) of copper(I) iodide, and 
0.2 mL of dry triethylamine in 4 mL of anhydrous THF was stirred at room 
temperature for 16h under inert atmosphere. The crude mixture was filtered through 
Celite, concentrated in vacuo, dissolved in diethyl ether, washed with water and brine, 
dried over MgSO4, and then concentrated in vacuo to provide the crude Sonogashira 
Coupling products 26 as a brown oil. Column chromatography (7:3 hexanes:ethyl 
acetate) was useful in removing unreacted phenylacetylene. A methanol flush of the 
column yielded 50 mg (81%) of the Sonogashira coupling products mixture 26 as a 
viscous, brown oil. Further specific characterization provided limited information, 
due to the complex product mixture and unworkable concentration of similar peaks in 
important areas of the 1H NMR spectrum. Selective NOE experiments were run on 
each set of aromatic peaks displayed in the 1H NMR. While most yielded no visible 
NOE signals, pulsing a doublet at δ 6.99 ppm provide NOE signal to protons at δ 2.28 
and 2.82 ppm, which are believed to correspond to the 5-position methyl group on 
either our pyridone 19 or pyridine 25 ring systems. This signifies the successful 




measurements of NOE signals originating from any coupling products to the 2-
position of 19 or 25 were unable to be observed. 
 







A mixture of 1.0 g (4.74 mmol) of hydroxypyridone ethyl ester 17 and 1.6 mL (4.5 g, 
16.6 mmol) of PBr3 was heated at 140 oC for 4 h. Once cool, water was added to the 
system and the resulting solution was brought to pH = 7 with NaHCO3. The 
precipitate thus obtained was filtered, washed with water and diethyl ether to yield 
415 mg (36%) of bromopyridone carboxylic acid 35 as an orange powder; IR (solid) 
3133 (br), 3000 (br), 2924 (br), 2812 (br), 1693 (m), 1637 (s), 1609 (s), 931 (s) cm-1; 
1H NMR (400 MHz, d-DMSO) δ 13.66 (br s, 1H), 12.65 (br s, 1H), 2.31 (s, 3H), 1.93 
(s, 3H); 13C NMR (100 MHz, d-DMSO) δ 172.9, 172.0, 164.6, 149.5, 107.7, 94.2, 
17.2, 8.9; MS (ESI+) m/z for C8H8BrNO3 (M)+ calcd 244.9688, found 245.9542. 
 










To a solution of 100 mg (0.45 mmol) of a 2 : 1 mixture of monobromopyridone 19 




dimethylformamide dimethyl acetal. The solution was stirred for 24 h at 140 oC under 
inert atmosphere. The resulting brown liquid was concentrated in vacuo to yield a 
crude mixture of enamine products 36 and 37 as a waxy, brown oil. An inability to 
separate the product mixture led to it being directly dissolved in 5 mL of 50% 
aqueous THF, then 0.29 g (1.35 mmol) of sodium periodate was added. The mixture 
was stirred vigorously for 16 h at room temperature under inert atmosphere. The 
resulting brown solution was filtered to remove insoluble NaIO3, and the solids were 
washed with ethyl acetate. The organic layer was separated and washed with 50 mL 
of saturated sodium bicarbonate solution three times, then dried over MgSO4. 
Concentration in vacuo of the organic layer provided 35 mg (29%) of a 10:1 mixture 
of monobromopyridone carboxyaldehyde 38 and dibromopyridine carboxyaldehyde 
39 as a brown powder. Purification by column chromatography (1:1 
dichloromethane:hexanes) removed some of the impurities. IR (CCl4, thin film) 2966 
(br), 2928 (br), 2850 (m), 1669 (s), 1650 (s) cm-1. The relative amounts of products 
present in the complex mixture was determined by the ratio of aldehydic proton 
signals (1H NMR (CDCl3) δ 10.02 (s, 0.12H), 10.21 (s, 1H)). Further spectral 
assignment proved difficult due to the overall level of impurity and spectral 
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